Introduction:The clinical spectrum of COVID-19 can range from asymptomatic to severe, with severe resulting in part from an intense inflammatory response. Selective serotonin reuptake inhibitor (SSRI) is the most commonly prescribed class of antidepressants and has anti-inflammatory and anti-platelet ...
COVID-19predictionrisk factorsseverity of diseaseBackground: With the outbreak of COVID-19 from Wuhan, Hubei Province, China since January 2020, there is a tremendous pressure on medical resources. We studiedoi:10.2139/ssrn.3539674Ji, Dong
Chest computed tomography (CT) is effective for assessing the severity of coronavirus disease 2019 (COVID-19). However, the clinical factors reflecting the disease progression of COVID-19 pneumonia on chest CT and predicting a subsequent exacerbation remain controversial. We conducted a retrospective ...
has rapidly spread to become a worldwide pandemic. Most COVID-19 patients have a mild clinical course, while a proportion of patients demonstrated rapid deterioration (particularly within 7–14 days) from the onset of symptoms into severe illness with or ...
Nitric oxide treatment can be pivotal in the world's fight against SARS-CoV-2, the coronavirus that causes COVID-19, according to a review from the George Washington University (GW). The article is published in the journal Nitric Oxide.
Fast and accurate clinical assessment of the disease progression and mortality is vital for the management of COVID-19 patients. Although several predictors have been proposed, they have been limited to subjective assessment, semi-automated schemes, or s
Background: Coronavirus disease 2019 (abbreviated as COVID-19) is a mysterious respiratory syndrome symptomatically spanning from healthy carriers to patients with life-threatening complications, in some cases, leading to a mournful death. For the time being, the contributory role of hematologists is...
In phase I and II studies and several case reports, recombinant ACE2 has been reported to improve the clinical course of patients with COVID-19 by increasing Ang II degradation.3–5 Along with Ang II, Ang III, and Ang IV may be responsible for severe forms of COVID-19. Ang II, a ...
Most importantly, we found 4 stages of COVID-19 progression with different patient statuses and mortality risks. We ranked 40 biomarkers related to disease and gave the reference values of them for each stage. Top 5 is Lymph, LDH, hs-CRP, Indirect Bilirubin, Creatinine. Besides, we have ...
Like many infectious diseases, COVID-19 can follow different courses, ranging from asymptomatic to fatal. Identifying robust biomarkers of COVID-19 severity, therefore, requires using a severity grading scale to stratify patients. The World Health Organization (WHO) ordinal scale is a com...